The second annual Wisconsin Science and Technology Symposium, to be held July 23 and 24, will bring together science and technology researchers, entrepreneurs, and investors from across the state to help them share ideas and spark new collaborations....
Expands intellectual property portfolio for multiplexing, detection of prokaryotic organisms MILWAUKEE - Prodesse Inc., a molecular diagnostics company focused on infectious disease, today announced that it has taken worldwide, non-exclusive sublicenses with Abbott for the Caskey (U.S. No. 5,582,989) and Stanbridge (U.S. No. 5,851,767)...
MADISON -Gentel Biosciences, Inc., a leading protein microarray technologies firm, announced today the availability of its APiX™ Chromogenic Protein Array System to the global research community. Composed of a user friendly scanner with optional analysis software, proprietary surface chemistry substrates, and licensed detection reagents, it...
BloodCenter of Wisconsin’s Diagnostic Laboratories has announced that it is the first laboratory in the United States to develop and offer a genetic test, known as “CEBPA Mutation Analysis,” for inherited acute myeloid leukemia (AML). AML is the second most common form of leukemia. The...
Clinical trials can be vexing, just ask anyone associated with Osiris Therapeutics, a leading stem cell therapeutic company. The company recently announced that their mid-stage, Phase II trials to treat chronic obstructive pulmonary disease (COPD) with adult stem cells (called Prochymal) did a great job...
The National Science Foundation has awarded a Phase I Small Business Innovation Research (SBIR) grant to Madison based life science tools company GWC Technologies. The grant will accelerate development of the company's technology for tests that analyze proteins, “Carbon-on-Metal” (CoM) technology for protein array...
Developers at the Medical College of Wisconsin Proteomics Center recently announced the release of the Virtual Proteomics Data Analysis Cluster, a proteomics data analysis tool that runs on Amazon's EC2 and S3 services. Users simply log into their EC2 accounts to start up their own...
Clinical trials can be vexing, just ask anyone associated with Osiris Therapeutics, a leading stem cell therapeutic company. The company recently announced that their mid-stage, Phase II trials to treat chronic obstructive pulmonary disease (COPD) with adult stem cells (called Prochymal) did a great job...
“Jumping the shark” is an expression that was coined by radio newscaster Jon Hein to capture the fact that a TV series has hit its peak and is in decline. I use this analogy to question whether the BIO organization has “jumped the shark” with...
CHALFONT ST. GILES, UK & MENLO PARK, Calif. - GE Healthcare, a unit of General Electric Company (NYSE: GE), and Geron Corporation (Nasdaq: GERN) today announced that they have entered into a global exclusive license and alliance agreement to develop and commercialize cellular assay products...